Fidelity Advisor Biotechnology Fund (FBTTX) Research
This fund primarily allocates its capital to common equities. A substantial portion, specifically at least 80% of its total assets, is dedicated to companies deeply involved in the biotechnology industry. This encompasses businesses engaged in the research, development, manufacturing, and distribution of biotechnological products, services, and processes, as well as those poised to benefit significantly from scientific and technological advancements in the field. Its investments span both domestic and international issuers. To select holdings, the fund employs a rigorous fundamental analysis, evaluating factors such as each company's financial strength, its competitive position within its industry, and broader market and economic conditions. It operates as a non-diversified fund.
Market snapshot
- Symbol
- FBTTX
- Price
- $36.13
- Day change
- +0.03%
- Market cap
- $1.9B
- 52-week range
- 23.45-36.93
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Fidelity Advisor China Region Fund Class C (FCHKX)
- Fidelity Advisor Diversified International Fund (FDVIX)
- Fidelity China Region Fund (FHKIX)
- Fidelity Utilities Fund (FIUIX)
- Federated Hermes MDT Large Cap Value Fund (FMSTX)
- Fidelity International Small Cap Opportunities Fund (FSCOX)
- Goldman Sachs Large Cap Growth Insights Fund (GLCGX)
- Goldman Sachs MLP Energy Infrastructure Fund (GLPIX)
Open Fidelity Advisor Biotechnology Fund (FBTTX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.